Procter & Gamble (PG) Financials

$146.44 +0.38 (+0.26%)

Closing price 05/8/2026 03:59 PM Eastern

Extended Trading

$146.50 +0.06 (+0.04%)

As of 05/8/2026 07:59 PM Eastern

Annual Income Statements for Procter & Gamble

This table shows Procter & Gamble's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/30/2015	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025
Net Income / (Loss) Attributable to Common Shareholders	7,036	10,508	15,326	9,750	3,897	13,027	14,306	14,742	14,653	14,879	15,974
Consolidated Net Income / (Loss)	7,144	10,604	15,411	9,861	3,966	13,103	14,352	14,793	14,738	14,974	16,065
Net Income / (Loss) Continuing Operations	8,287	10,027	10,194	9,861	3,966	13,103	14,352	14,793	14,738	14,974	16,065
Total Pre-Tax Income	11,012	13,369	13,257	13,326	6,069	15,834	17,615	17,995	18,353	18,761	20,167
Total Operating Income	11,049	13,441	13,766	13,363	5,487	15,706	17,986	17,813	18,134	18,545	20,451
Total Gross Profit	33,693	32,390	32,420	32,400	32,916	35,700	39,010	38,030	39,246	43,191	43,120
Total Revenue	70,749	65,299	65,058	66,832	67,684	70,950	76,118	80,187	82,006	84,039	84,284
Operating Revenue	70,749	65,299	65,058	66,832	67,684	70,950	76,118	80,187	82,006	84,039	84,284
Total Cost of Revenue	37,056	32,909	32,638	34,432	34,768	35,250	37,108	42,157	42,760	40,848	41,164
Operating Cost of Revenue	37,056	32,909	32,638	34,432	34,768	35,250	37,108	42,157	42,760	40,848	41,164
Total Operating Expenses	22,644	18,949	18,654	19,037	27,429	19,994	21,024	20,217	21,112	24,646	22,669
Selling, General & Admin Expense	20,616	18,949	18,654	19,037	19,084	19,994	21,024	20,217	21,112	23,305	22,669
Impairment Charge	-	-	0.00	0.00	8,345	-	-	0.00	0.00	1,341	0.00
Total Other Income / (Expense), net	-37	-72	-509	-37	582	128	-371	182	219	216	-284
Interest Expense	626	579	465	506	509	465	502	439	756	925	907
Interest & Investment Income	149	182	171	247	220	155	45	51	307	473	469
Other Income / (Expense), net	440	325	-215	222	871	438	86	570	668	668	154
Income Tax Expense	2,725	3,342	3,063	3,465	2,103	2,731	3,263	3,202	3,615	3,787	4,102
Net Income / (Loss) Attributable to Noncontrolling Interest	108	96	85	111	69	76	46	51	85	95	91
Basic Earnings per Share	$2.50	$3.80	$5.80	$3.75	$1.45	$5.13	$5.69	$6.00	$6.07	$6.18	$6.67
Weighted Average Basic Shares Outstanding	-16.75B	50.04B	2.60B	2.49B	2.50B	4.97B	4.85B	4.78B	4.71B	2.35B	2.34B
Diluted Earnings per Share	$2.44	$3.69	$5.59	$3.67	$1.43	$4.96	$5.50	$5.81	$5.90	$6.02	$6.51
Weighted Average Diluted Shares Outstanding	-16.75B	50.04B	2.60B	2.49B	2.50B	4.97B	4.85B	4.78B	4.71B	2.35B	2.34B
Weighted Average Basic & Diluted Shares Outstanding	-16.75B	50.04B	2.60B	2.49B	2.50B	4.97B	4.85B	4.78B	4.71B	2.35B	2.34B
Cash Dividends to Common per Share	$2.59	$2.66	$3.00	-	$2.90	$3.03	$3.24	$3.52	$3.68	$3.83	$4.08

This table shows Procter & Gamble's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Income / (Loss) Attributable to Common Shareholders	4,521	3,468	3,754	3,136	3,959	4,630	3,769	3,616	4,750	4,319	3,932
Consolidated Net Income / (Loss)	4,556	3,493	3,781	3,144	3,987	4,659	3,793	3,626	4,781	4,331	3,951
Net Income / (Loss) Continuing Operations	4,556	3,493	3,780	3,145	3,988	4,658	3,793	3,626	4,781	4,331	3,950
Total Pre-Tax Income	5,802	4,496	4,592	3,871	5,140	5,845	4,661	4,521	6,034	5,421	4,989
Total Operating Income	5,767	4,433	4,460	3,885	5,797	5,741	4,558	4,355	5,856	5,366	4,576
Total Gross Profit	11,370	11,297	10,340	10,184	11,316	11,464	10,082	10,258	11,499	11,374	10,513
Total Revenue	21,871	21,441	20,195	20,532	21,737	21,882	19,776	20,889	22,386	22,208	21,235
Operating Revenue	21,871	21,441	20,195	20,532	21,737	21,882	19,776	20,889	22,386	22,208	21,235
Total Cost of Revenue	10,501	10,144	9,855	10,348	10,421	10,418	9,694	10,631	10,887	10,834	10,722
Operating Cost of Revenue	10,501	10,144	9,855	10,348	10,421	10,418	9,694	10,631	10,887	10,834	10,722
Total Operating Expenses	5,604	6,863	5,880	6,299	5,519	5,723	5,524	5,903	5,643	6,008	5,936
Selling, General & Admin Expense	5,604	5,522	5,880	6,299	5,519	5,723	5,524	5,903	5,643	6,008	5,936
Total Other Income / (Expense), net	35	62	131	-12	-657	103	104	166	179	55	414
Interest Expense	225	248	233	219	238	240	217	212	197	220	223
Interest & Investment Income	128	133	104	108	135	119	111	104	108	115	100
Other Income / (Expense), net	132	177	260	99	-554	224	210	274	268	160	537
Income Tax Expense	1,246	1,003	812	726	1,152	1,187	868	895	1,253	1,090	1,039
Net Income / (Loss) Attributable to Noncontrolling Interest	35	25	27	8.00	28	29	23	11	31	12	18
Basic Earnings per Share	$1.89	$1.44	$1.56	$1.29	$1.65	$1.94	$1.58	$1.50	$2.00	$1.82	$1.66
Weighted Average Basic Shares Outstanding	2.36B	2.35B	2.36B	2.35B	2.36B	2.34B	2.34B	2.34B	2.34B	2.32B	2.33B
Diluted Earnings per Share	$1.83	$1.40	$1.52	$1.27	$1.61	$1.88	$1.54	$1.48	$1.95	$1.78	$1.63
Weighted Average Diluted Shares Outstanding	2.36B	2.35B	2.36B	2.35B	2.36B	2.34B	2.34B	2.34B	2.34B	2.32B	2.33B
Weighted Average Basic & Diluted Shares Outstanding	2.36B	2.35B	2.36B	2.35B	2.36B	2.34B	2.34B	2.34B	2.34B	2.32B	2.33B
Cash Dividends to Common per Share	$0.94	$0.94	$0.94	-	-	$1.01	$1.01	-	-	$1.06	$1.06

This table details how cash moves in and out of Procter & Gamble's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/30/2015	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025
Net Change in Cash & Equivalents	-1,712	266	-2,529	-3,000	1,758	11,942	-5,893	-3,074	1,032	1,235	75
Net Cash From Operating Activities	14,608	15,435	12,753	14,867	15,242	17,403	18,371	16,723	16,848	19,846	17,817
Net Cash From Continuing Operating Activities	14,608	15,435	12,753	14,867	15,242	17,403	18,371	16,723	16,848	19,847	17,818
Net Income / (Loss) Continuing Operations	7,144	10,604	15,411	9,861	3,966	13,103	14,352	14,793	14,738	14,974	16,065
Consolidated Net Income / (Loss)	7,144	10,604	15,411	9,861	3,966	13,103	14,352	14,793	14,738	14,974	16,065
Depreciation Expense	3,134	3,078	2,820	2,834	2,824	3,013	2,735	2,807	2,714	2,896	2,847
Non-Cash Adjustments To Reconcile Net Income	4,519	928	-4,434	-1,279	8,495	-31	778	41	722	1,935	-273
Changes in Operating Assets and Liabilities, net	-189	825	-1,044	3,451	-43	1,318	506	-918	-1,326	42	-821
Net Cash From Investing Activities	-2,890	-5,575	-6,685	-3,511	-3,490	3,045	-2,834	-4,424	-3,500	-3,504	-3,818
Net Cash From Continuing Investing Activities	-2,890	-5,575	-6,210	-3,511	-3,490	3,045	-2,834	-4,424	-3,500	-3,504	-3,818
Purchase of Property, Plant & Equipment	-3,736	-3,314	-3,384	-3,717	-3,347	-3,073	-2,787	-3,156	-3,062	-3,322	-3,773
Acquisitions	-137	-186	-16	-109	-3,945	-58	-34	-1,381	-765	-21	-11
Sale of Property, Plant & Equipment	4,498	432	571	269	394	30	42	110	46	346	107
Sale and/or Maturity of Investments	1,040	1,447	1,488	3,955	3,628	6,146	-55	3.00	281	-507	-141
Net Cash From Financing Activities	-13,019	-9,213	-8,568	-14,375	-9,994	-8,367	-21,531	-14,876	-12,146	-14,855	-14,036
Net Cash From Continuing Financing Activities	-13,019	-9,213	-8,568	-14,375	-9,994	-8,367	-21,531	-14,876	-12,146	-14,855	-14,035
Repayment of Debt	-6,092	-2,631	-4,931	-6,310	-3,184	-14,473	-15,995	-12,904	-18,228	-9,167	-9,627
Repurchase of Common Equity	-4,604	-4,004	-5,204	-7,004	-5,003	-7,405	-11,009	-10,003	-7,353	-5,006	-6,500
Payment of Dividends	-7,287	-7,436	-7,236	-7,310	-7,498	-7,789	-8,263	-8,770	-8,999	-9,312	-9,872
Issuance of Debt	2,138	3,916	6,330	5,072	2,367	19,322	12,092	14,796	21,165	6,725	10,257
Other Financing Activities, net	2,826	942	2,473	1,177	3,324	1,978	1,644	2,005	1,269	1,905	1,707
Other Net Changes in Cash	-	-	-	19	-	-139	101	-497	-170	-251	112
Cash Interest Paid	678	569	518	529	497	434	531	451	721	878	896
Cash Income Taxes Paid	4,558	3,730	3,714	2,830	3,064	3,550	3,822	3,818	4,278	4,363	4,554

This table details how cash moves in and out of Procter & Gamble's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
Net Change in Cash & Equivalents	1,487	-1,843	-1,111	2,653	2,675	-1,927	-1,113	440	1,615	-346	1,480
Net Cash From Operating Activities	4,904	5,100	4,088	5,754	4,302	4,825	3,705	4,985	5,408	4,972	4,045
Net Cash From Continuing Operating Activities	4,904	5,100	4,089	5,754	4,302	4,825	3,704	4,987	5,409	4,972	4,044
Net Income / (Loss) Continuing Operations	4,556	3,493	3,781	3,144	3,987	4,659	3,793	3,626	4,781	4,331	3,951
Consolidated Net Income / (Loss)	4,556	3,493	3,781	3,144	3,987	4,659	3,793	3,626	4,781	4,331	3,951
Depreciation Expense	702	721	712	761	728	706	690	723	761	802	785
Non-Cash Adjustments To Reconcile Net Income	224	1,735	-442	1,140	-365	80	201	-1,637	-226	-156	-446
Changes in Operating Assets and Liabilities, net	-578	-849	38	709	-48	-620	-980	2,275	93	-5.00	-246
Net Cash From Investing Activities	-1,222	-1,002	-762	-518	-1,108	-921	-726	-1,063	-1,535	-1,228	-665
Net Cash From Continuing Investing Activities	-1,222	-1,001	-763	-518	-1,108	-922	-727	-1,061	-1,535	-1,229	-664
Purchase of Property, Plant & Equipment	-925	-817	-797	-783	-993	-925	-859	-996	-1,200	-1,167	-1,019
Acquisitions	0.00	-	-	-	-6.00	-	-5.00	-	-5.00	-	-80
Sale of Property, Plant & Equipment	3.00	5.00	69	269	45	2.00	17	43	8.00	8.00	485
Sale and/or Maturity of Investments	-300	-189	-	-4.00	-154	1.00	120	-108	-338	-70	-50
Net Cash From Financing Activities	-2,038	-6,049	-4,269	-2,499	-634	-5,571	-4,215	-3,616	-2,239	-4,088	-1,827
Net Cash From Continuing Financing Activities	-2,037	-6,052	-4,267	-2,499	-634	-5,570	-4,216	-3,615	-2,237	-4,090	-1,826
Repayment of Debt	-738	-3,719	670	-1,640	-1,085	-3,669	-1,048	-3,825	305	-4,580	-3,411
Repurchase of Common Equity	-1,500	-1,003	-987	-1,516	-1,939	-2,510	-1,351	-700	-1,250	-2,278	-625
Payment of Dividends	-2,290	-2,288	-2,285	-2,449	-2,445	-2,441	-2,433	-2,553	-2,549	-2,544	-2,530
Issuance of Debt	2,179	873	-2,233	2,166	4,090	2,810	-	3,357	1,123	5,238	4,076
Other Financing Activities, net	312	85	568	940	745	240	616	106	134	74	664
Effect of Exchange Rate Changes	-	-	-	-	116	-	122	-	-20	-1.00	-73

This table presents Procter & Gamble's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/30/2015	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025
Total Assets	129,495	127,136	120,406	118,310	115,095	120,700	119,307	117,208	120,829	122,370	125,231
Total Current Assets	29,646	33,782	26,494	23,320	22,473	27,987	23,091	21,653	22,648	24,709	25,392
Cash & Equivalents	6,836	7,102	5,569	2,569	4,239	-	10,288	-	8,246	9,482	9,556
Accounts Receivable	4,568	4,373	4,594	4,686	4,951	4,178	4,725	5,143	5,471	6,118	6,185
Inventories, net	4,979	4,716	4,624	4,738	5,017	5,498	5,983	6,924	7,073	7,016	7,550
Prepaid Expenses	2,708	2,653	2,139	2,046	2,218	2,130	2,095	2,372	1,858	2,095	2,100
Plant, Property, & Equipment, net	19,655	19,385	19,893	20,600	21,271	20,692	21,686	21,195	21,909	22,152	23,897
Total Noncurrent Assets	80,194	73,969	74,019	74,390	71,351	72,021	74,530	74,360	76,272	75,508	75,941
Goodwill	44,622	44,350	44,699	45,175	40,273	39,901	40,924	39,700	40,659	40,303	41,650
Intangible Assets	25,010	24,527	24,187	23,902	24,215	23,792	23,642	23,679	23,783	22,047	21,910
Other Noncurrent Operating Assets	5,358	5,092	5,133	5,313	6,863	8,328	9,964	10,981	11,830	13,158	12,381
Total Liabilities & Shareholders' Equity	129,495	127,136	120,406	118,310	115,095	120,700	119,307	117,208	120,829	122,370	125,231
Total Liabilities	66,445	69,153	64,628	65,427	67,516	73,822	72,653	70,354	73,764	71,811	72,946
Total Current Liabilities	29,790	30,770	30,210	28,237	30,011	32,976	33,132	33,081	35,756	33,627	36,058
Short-Term Debt	12,018	11,653	13,554	10,423	9,697	11,183	8,889	8,645	10,229	7,191	9,513
Accounts Payable	8,138	9,325	9,632	10,344	11,260	12,071	13,720	14,882	14,598	15,364	15,227
Accrued Expenses	8,091	7,449	7,024	7,470	9,054	9,722	10,523	9,554	10,929	11,073	11,318
Total Noncurrent Liabilities	36,655	38,383	34,418	37,190	37,505	40,846	39,521	37,273	38,008	38,183	36,889
Long-Term Debt	18,327	18,945	18,038	20,863	20,395	23,537	23,099	22,848	24,378	25,269	24,995
Noncurrent Deferred & Payable Income Tax Liabilities	9,179	9,113	8,126	6,163	6,899	6,199	6,153	6,809	6,478	6,516	5,774
Other Noncurrent Operating Liabilities	8,432	10,325	8,254	10,164	10,211	11,110	10,269	7,616	7,152	6,398	6,120
Total Equity & Noncontrolling Interests	63,050	57,983	55,778	52,883	47,579	46,878	46,654	46,854	47,065	50,559	52,284
Total Preferred & Common Equity	62,419	57,341	55,184	52,293	47,194	46,424	46,308	46,589	46,777	50,286	52,012
Preferred Stock	1,077	1,038	1,006	967	928	800	800	843	819	798	777
Total Common Equity	61,342	56,303	54,178	51,326	46,266	45,624	45,508	45,746	45,958	49,488	51,235
Common Stock	67,861	67,723	67,650	67,855	67,836	68,203	68,857	69,804	70,565	71,693	72,779
Retained Earnings	84,807	87,953	96,124	98,641	94,918	100,239	106,374	112,429	118,170	123,811	129,973
Treasury Stock	-77,226	-82,176	-93,715	-99,217	-100,406	-105,573	-114,973	-123,382	-129,736	-133,379	-138,702
Accumulated Other Comprehensive Income / (Loss)	-12,780	-15,907	-14,632	-14,749	-14,936	-16,165	-13,744	-12,189	-12,220	-11,900	-12,143
Other Equity Adjustments	-1,320	-1,290	-1,249	-1,204	-1,146	-1,080	-1,006	-916	-821	-737	-672
Noncontrolling Interest	631	642	594	590	385	357	276	265	288	272	272

This table presents Procter & Gamble's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	6/30/2023	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	9/30/2025	12/31/2025	3/31/2026
Total Assets	120,829	122,531	120,709	119,598	122,370	126,482	122,639	122,984	127,599	127,286	128,378
Total Current Assets	22,648	24,940	23,111	22,458	24,709	27,449	25,642	24,435	27,118	26,588	27,987
Cash & Equivalents	8,246	-	-	6,828	9,482	12,156	10,230	9,116	11,171	10,825	12,306
Accounts Receivable	5,471	6,215	6,334	6,124	6,118	6,314	6,234	6,139	6,487	6,279	6,322
Inventories, net	7,073	7,117	7,152	7,078	7,016	7,287	7,020	7,400	7,848	7,818	7,853
Prepaid Expenses	1,858	1,875	1,736	2,428	2,095	1,692	2,158	1,780	1,612	1,666	1,506
Plant, Property, & Equipment, net	21,909	21,636	22,132	22,027	22,152	22,506	22,074	22,728	24,119	24,487	24,574
Total Noncurrent Assets	76,272	75,955	75,466	75,113	75,508	76,526	74,923	75,820	76,362	76,211	75,818
Goodwill	40,659	40,239	40,916	40,567	40,303	40,970	39,898	40,476	41,643	41,665	41,359
Intangible Assets	23,783	23,637	22,302	22,193	22,047	22,053	21,833	21,836	21,818	21,737	21,531
Other Noncurrent Operating Assets	11,830	12,079	12,248	12,353	13,158	13,503	13,192	13,508	12,901	12,809	12,928
Total Liabilities & Shareholders' Equity	120,829	122,531	120,709	119,598	122,370	126,482	122,639	122,984	127,599	127,286	128,378
Total Liabilities	73,764	74,517	71,880	69,264	71,811	74,341	71,195	70,439	74,048	73,969	73,647
Total Current Liabilities	35,756	37,158	35,950	32,340	33,627	36,420	33,797	34,248	37,995	36,699	38,235
Short-Term Debt	10,229	11,811	10,616	7,729	7,191	10,409	9,424	9,889	11,631	11,062	13,174
Accounts Payable	14,598	14,435	14,234	13,691	15,364	15,350	14,495	14,512	15,609	15,173	15,030
Accrued Expenses	10,929	10,912	11,100	10,921	11,073	10,661	9,879	9,847	10,756	10,463	10,031
Total Noncurrent Liabilities	38,008	37,360	35,929	36,923	38,183	37,921	37,399	36,191	36,052	37,270	35,412
Long-Term Debt	24,378	24,069	23,096	24,253	25,269	25,744	25,263	24,252	24,315	25,577	23,852
Noncurrent Deferred & Payable Income Tax Liabilities	6,478	6,814	6,219	6,284	6,516	6,420	6,725	6,481	5,893	5,974	6,047
Other Noncurrent Operating Liabilities	7,152	6,477	6,614	6,386	6,398	5,757	5,411	5,458	5,844	5,719	5,513
Total Equity & Noncontrolling Interests	47,065	48,014	48,829	50,333	50,559	52,141	51,443	52,545	53,551	53,317	54,731
Total Preferred & Common Equity	46,777	47,692	48,534	50,058	50,286	51,840	51,168	52,272	53,270	53,041	54,505
Preferred Stock	819	812	809	801	798	791	788	781	770	767	759
Total Common Equity	45,958	46,880	47,725	49,257	49,488	51,049	50,380	51,491	52,500	52,274	53,746
Common Stock	70,565	70,831	70,944	71,404	71,693	72,111	72,292	72,624	72,926	73,019	73,384
Retained Earnings	118,170	120,443	121,617	123,132	123,811	125,361	127,544	128,919	132,212	133,981	135,424
Treasury Stock	-129,736	-131,029	-131,887	-132,172	-133,379	-134,823	-137,112	-138,073	-139,845	-141,981	-142,168
Accumulated Other Comprehensive Income / (Loss)	-12,220	-12,583	-12,167	-12,370	-11,900	-10,893	-11,637	-11,307	-12,156	-12,108	-12,298
Other Equity Adjustments	-821	-782	-782	-737	-737	-707	-707	-672	-637	-637	-596
Noncontrolling Interest	288	321	294	275	272	300	275	273	281	276	226

This table displays calculated financial ratios and metrics derived from Procter & Gamble's official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Period end date	6/30/2015	6/30/2016	6/30/2017	6/30/2018	6/30/2019	6/30/2020	6/30/2021	6/30/2022	6/30/2023	6/30/2024	6/30/2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-4.91%	-7.70%	-0.37%	2.73%	1.27%	4.83%	7.28%	5.35%	2.27%	2.48%	0.29%
EBITDA Growth	-15.28%	15.19%	-2.81%	0.29%	-44.08%	108.64%	8.61%	1.84%	1.54%	2.76%	6.07%
EBIT Growth	-18.63%	19.82%	-1.56%	0.25%	-53.20%	153.92%	11.94%	1.72%	2.28%	2.19%	7.25%
NOPAT Growth	-24.23%	21.24%	5.00%	-6.58%	-63.74%	262.47%	12.75%	-0.07%	-0.55%	1.64%	10.06%
Net Income Growth	-39.38%	48.43%	45.33%	-36.01%	-59.78%	230.38%	9.53%	3.07%	-0.37%	1.60%	7.29%
EPS Growth	-39.15%	51.23%	51.49%	-34.35%	-61.04%	246.85%	10.89%	5.64%	1.55%	2.03%	8.14%
Operating Cash Flow Growth	4.66%	5.66%	-17.38%	16.58%	2.52%	14.18%	5.56%	-8.97%	0.75%	17.79%	-10.22%
Free Cash Flow Firm Growth	107.01%	-46.60%	-38.02%	12.11%	-13.08%	75.62%	-21.70%	1.26%	3.41%	19.73%	-14.26%
Invested Capital Growth	-19.57%	-5.41%	2.62%	0.12%	-6.82%	-2.92%	4.49%	4.07%	3.22%	0.15%	5.03%
Revenue Q/Q Growth	5.55%	-0.69%	-0.04%	0.64%	0.88%	0.86%	1.67%	0.71%	1.28%	-0.03%	0.43%
EBITDA Q/Q Growth	-7.42%	10.88%	0.53%	-3.54%	-44.28%	81.39%	-0.16%	0.43%	2.85%	-1.42%	2.66%
EBIT Q/Q Growth	-9.14%	13.36%	1.54%	-4.45%	-53.68%	114.05%	0.39%	0.43%	3.37%	-1.90%	3.23%
NOPAT Q/Q Growth	-15.33%	18.36%	2.00%	0.28%	-67.29%	165.85%	0.60%	0.87%	2.25%	-1.20%	2.11%
Net Income Q/Q Growth	-22.57%	15.46%	1.61%	-3.07%	-64.25%	157.93%	0.86%	1.02%	2.32%	-1.63%	3.09%
EPS Q/Q Growth	-22.54%	16.04%	2.38%	-2.39%	-66.03%	169.57%	1.29%	1.22%	2.79%	-1.63%	3.33%
Operating Cash Flow Q/Q Growth	-3.42%	0.99%	-3.42%	3.56%	-0.31%	3.91%	-3.59%	-2.38%	10.70%	2.13%	-4.14%
Free Cash Flow Firm Q/Q Growth	550.98%	-3.44%	-36.61%	69.44%	-11.93%	4.43%	-18.56%	14.45%	14.51%	5.61%	-9.21%
Invested Capital Q/Q Growth	-7.14%	-4.94%	2.26%	-3.20%	-11.34%	-1.72%	2.42%	0.34%	-1.33%	-2.58%	-0.43%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	47.62%	49.60%	49.83%	48.48%	48.63%	50.32%	51.25%	47.43%	47.86%	51.39%	51.16%
EBITDA Margin	20.67%	25.80%	25.16%	24.57%	13.57%	27.00%	27.34%	26.43%	26.24%	26.31%	27.83%
Operating Margin	15.62%	20.58%	21.16%	19.99%	8.11%	22.14%	23.63%	22.21%	22.11%	22.07%	24.26%
EBIT Margin	16.24%	21.08%	20.83%	20.33%	9.39%	22.75%	23.74%	22.93%	22.93%	22.86%	24.45%
Profit (Net Income) Margin	10.10%	16.24%	23.69%	14.75%	5.86%	18.47%	18.85%	18.45%	17.97%	17.82%	19.06%
Tax Burden Percent	64.87%	79.32%	116.25%	74.00%	65.35%	82.75%	81.48%	82.21%	80.30%	79.81%	79.66%
Interest Burden Percent	95.85%	97.12%	97.83%	98.09%	95.45%	98.08%	97.47%	97.89%	97.61%	97.65%	97.87%
Effective Tax Rate	24.75%	25.00%	23.10%	26.00%	34.65%	17.25%	18.52%	17.79%	19.70%	20.19%	20.34%
Return on Invested Capital (ROIC)	9.96%	13.92%	14.84%	13.68%	5.13%	19.57%	21.91%	21.00%	20.15%	20.14%	21.61%
ROIC Less NNEP Spread (ROIC-NNEP)	3.06%	18.32%	48.28%	13.53%	7.07%	20.13%	20.41%	21.65%	20.84%	20.84%	20.67%
Return on Net Nonoperating Assets (RNNOA)	0.78%	3.60%	12.25%	4.47%	2.76%	8.17%	8.78%	10.64%	11.24%	10.53%	9.63%
Return on Equity (ROE)	10.74%	17.52%	27.09%	18.15%	7.90%	27.74%	30.69%	31.64%	31.38%	30.68%	31.24%
Cash Return on Invested Capital (CROIC)	31.65%	19.48%	12.26%	13.56%	12.20%	22.54%	17.52%	17.01%	16.97%	19.99%	16.71%
Operating Return on Assets (OROA)	8.39%	10.73%	10.95%	11.38%	5.45%	13.69%	15.06%	15.54%	15.80%	15.80%	16.64%
Return on Assets (ROA)	5.22%	8.26%	12.45%	8.26%	3.40%	11.11%	11.96%	12.51%	12.38%	12.31%	12.98%
Return on Common Equity (ROCE)	10.45%	17.03%	26.31%	17.62%	7.67%	26.99%	29.90%	30.88%	30.64%	29.99%	30.60%
Return on Equity Simple (ROE_SIMPLE)	11.45%	18.49%	27.93%	18.86%	8.40%	28.22%	30.99%	31.75%	31.51%	29.78%	0.00%
Net Operating Profit after Tax (NOPAT)	8,315	10,081	10,585	9,888	3,586	12,997	14,654	14,643	14,562	14,802	16,291
NOPAT Margin	11.75%	15.44%	16.27%	14.80%	5.30%	18.32%	19.25%	18.26%	17.76%	17.61%	19.33%
Net Nonoperating Expense Percent (NNEP)	6.91%	-4.40%	-33.44%	0.15%	-1.94%	-0.55%	1.50%	-0.65%	-0.69%	-0.70%	0.94%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	-	-	-	18.77%
Cost of Revenue to Revenue	52.38%	50.40%	50.17%	51.52%	51.37%	49.68%	48.75%	52.57%	52.14%	48.61%	48.84%
SG&A Expenses to Revenue	29.14%	29.02%	28.67%	28.48%	28.20%	28.18%	27.62%	25.21%	25.74%	27.73%	26.90%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	32.01%	29.02%	28.67%	28.48%	40.53%	28.18%	27.62%	25.21%	25.74%	29.33%	26.90%
Earnings before Interest and Taxes (EBIT)	11,489	13,766	13,551	13,585	6,358	16,144	18,072	18,383	18,802	19,213	20,605
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	14,623	16,844	16,371	16,419	9,182	19,157	20,807	21,190	21,516	22,109	23,452
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.70	3.23	3.43	3.29	5.28	5.91	6.78	7.12	7.54	7.82	7.24
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	2.34	2.79	2.85	2.53	3.61	3.80	4.05	4.06	4.23	4.60	4.40
Price to Earnings (P/E)	23.55	17.32	12.11	17.32	62.73	20.71	21.57	22.10	23.66	26.00	23.23
Dividend Yield	4.25%	4.86%	3.72%	4.15%	2.97%	2.78%	2.57%	2.59%	2.50%	2.34%	2.58%
Earnings Yield	4.25%	5.77%	8.25%	5.77%	1.59%	4.83%	4.64%	4.53%	4.23%	3.85%	4.31%
Enterprise Value to Invested Capital (EV/IC)	2.50	2.85	2.82	2.62	3.94	4.43	4.85	4.94	5.09	5.59	5.14
Enterprise Value to Revenue (EV/Rev)	2.63	3.08	3.13	2.84	3.92	4.08	4.35	4.38	4.56	4.89	4.71
Enterprise Value to EBITDA (EV/EBITDA)	12.73	11.93	12.44	11.56	28.92	15.11	15.92	16.57	17.39	18.59	16.93
Enterprise Value to EBIT (EV/EBIT)	16.20	14.60	15.03	13.97	41.77	17.94	18.33	19.10	19.90	21.39	19.27
Enterprise Value to NOPAT (EV/NOPAT)	22.39	19.93	19.25	19.20	74.06	22.28	22.61	23.98	25.69	27.76	24.37
Enterprise Value to Operating Cash Flow (EV/OCF)	12.74	13.02	15.97	12.77	17.42	16.64	18.03	21.00	22.20	20.71	22.28
Enterprise Value to Free Cash Flow (EV/FCFF)	7.05	14.24	23.30	19.37	31.17	19.35	28.27	29.60	30.49	27.98	31.52
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.48	0.53	0.57	0.59	0.63	0.74	0.69	0.67	0.74	0.64	0.66
Long-Term Debt to Equity	0.29	0.33	0.32	0.39	0.43	0.50	0.50	0.49	0.52	0.50	0.48
Financial Leverage	0.25	0.20	0.25	0.33	0.39	0.41	0.43	0.49	0.54	0.51	0.47
Leverage Ratio	2.06	2.12	2.18	2.20	2.32	2.50	2.57	2.53	2.53	2.49	2.41
Compound Leverage Factor	1.97	2.06	2.13	2.16	2.22	2.45	2.50	2.48	2.47	2.43	2.36
Debt to Total Capital	32.49%	34.54%	36.16%	37.17%	38.74%	42.55%	40.68%	40.20%	42.37%	39.10%	39.76%
Short-Term Debt to Total Capital	12.87%	13.16%	15.51%	12.38%	12.48%	13.71%	11.30%	11.03%	12.52%	8.66%	10.96%
Long-Term Debt to Total Capital	19.62%	21.39%	20.65%	24.79%	26.26%	28.85%	29.37%	29.16%	29.85%	30.44%	28.80%
Preferred Equity to Total Capital	1.15%	1.17%	1.15%	1.15%	1.19%	0.98%	1.02%	1.08%	1.00%	0.96%	0.90%
Noncontrolling Interests to Total Capital	0.68%	0.72%	0.68%	0.70%	0.50%	0.44%	0.35%	0.34%	0.35%	0.33%	0.31%
Common Equity to Total Capital	65.68%	63.56%	62.01%	60.98%	59.57%	55.91%	57.87%	58.39%	56.27%	59.61%	59.03%
Debt to EBITDA	2.08	1.82	1.93	1.91	3.28	1.81	1.54	1.49	1.61	1.47	1.47
Net Debt to EBITDA	1.28	1.02	1.01	1.18	2.16	0.97	1.04	1.15	1.23	1.04	1.06
Long-Term Debt to EBITDA	1.25	1.12	1.10	1.27	2.22	1.23	1.11	1.08	1.13	1.14	1.07
Debt to NOPAT	3.65	3.04	2.98	3.16	8.39	2.67	2.18	2.15	2.38	2.19	2.12
Net Debt to NOPAT	2.25	1.71	1.55	1.97	5.52	1.43	1.48	1.66	1.81	1.55	1.53
Long-Term Debt to NOPAT	2.20	1.88	1.70	2.11	5.69	1.81	1.58	1.56	1.67	1.71	1.53
Altman Z-Score	3.25	3.45	3.72	3.61	4.02	4.34	4.83	5.21	5.25	5.77	5.62
Noncontrolling Interest Sharing Ratio	2.69%	2.80%	2.88%	2.91%	2.86%	2.72%	2.57%	2.41%	2.36%	2.23%	2.06%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.00	1.10	0.88	0.83	0.75	0.85	0.70	0.65	0.63	0.73	0.70
Quick Ratio	0.54	0.58	0.65	0.59	0.51	0.13	0.45	0.16	0.38	0.46	0.44
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	26,417	14,106	8,743	9,802	8,521	14,964	11,717	11,864	12,269	14,690	12,595
Operating Cash Flow to CapEx	0.00%	535.57%	453.36%	431.18%	516.15%	571.90%	669.25%	549.02%	558.62%	666.87%	486.01%
Free Cash Flow to Firm to Interest Expense	42.20	24.36	18.80	19.37	16.74	32.18	23.34	27.03	16.23	15.88	13.89
Operating Cash Flow to Interest Expense	23.34	26.66	27.43	29.38	29.95	37.43	36.60	38.09	22.29	21.46	19.64
Operating Cash Flow Less CapEx to Interest Expense	24.55	21.68	21.38	22.57	24.14	30.88	31.13	31.15	18.30	18.24	15.60
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.52	0.51	0.53	0.56	0.58	0.60	0.63	0.68	0.69	0.69	0.68
Accounts Receivable Turnover	12.92	14.61	14.51	14.40	14.05	15.54	17.10	16.25	15.45	14.50	13.70
Inventory Turnover	6.31	6.79	6.99	7.36	7.13	6.70	6.46	6.53	6.11	5.80	5.65
Fixed Asset Turnover	3.37	3.35	3.31	3.30	3.23	3.38	3.59	3.74	3.81	3.81	3.66
Accounts Payable Turnover	4.46	3.77	3.44	3.45	3.22	3.02	2.88	2.95	2.90	2.73	2.69
Days Sales Outstanding (DSO)	28.26	24.99	25.15	25.34	25.98	23.48	21.35	22.46	23.62	25.17	26.64
Days Inventory Outstanding (DIO)	57.81	53.76	52.23	49.62	51.20	54.44	56.46	55.88	59.74	62.95	64.58
Days Payable Outstanding (DPO)	81.75	96.84	106.00	105.88	113.40	120.79	126.84	123.82	125.82	133.86	135.62
Cash Conversion Cycle (CCC)	4.32	-18.09	-28.62	-30.92	-36.21	-42.87	-49.03	-45.49	-42.46	-45.75	-44.41
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	74,416	70,391	72,233	72,319	67,384	65,417	68,354	71,133	73,426	73,538	77,234
Invested Capital Turnover	0.85	0.90	0.91	0.92	0.97	1.07	1.14	1.15	1.13	1.14	1.12
Increase / (Decrease) in Invested Capital	-18,102	-4,025	1,842	86	-4,935	-1,967	2,937	2,779	2,293	112	3,696
Enterprise Value (EV)	186,145	200,934	203,721	189,826	265,560	289,544	331,297	351,159	374,097	410,956	396,997
Market Capitalization	165,695	182,004	185,666	168,833	244,442	269,848	308,521	325,772	346,629	386,908	370,996
Book Value per Share	$22.61	$21.15	$21.18	$20.41	$18.44	$18.43	$18.59	$19.07	$19.50	$20.97	$21.85
Tangible Book Value per Share	($3.06)	($4.72)	($5.75)	($7.06)	($7.26)	($7.30)	($7.78)	($7.35)	($7.84)	($5.45)	($5.26)
Total Capital	93,395	88,581	87,370	84,169	77,671	81,598	78,642	78,347	81,672	83,019	86,792
Total Debt	30,345	30,598	31,592	31,286	30,092	34,720	31,988	31,493	34,607	32,460	34,508
Total Long-Term Debt	18,327	18,945	18,038	20,863	20,395	23,537	23,099	22,848	24,378	25,269	24,995
Net Debt	18,742	17,250	16,455	19,436	19,805	18,539	21,700	24,279	26,361	22,978	24,952
Capital Expenditures (CapEx)	-762	2,882	2,813	3,448	2,953	3,043	2,745	3,046	3,016	2,976	3,666
Debt-free, Cash-free Net Working Capital (DFCFNWC)	271	1,317	-5,299	-6,344	-8,128	-9,987	-11,440	-9,997	-11,125	-11,209	-10,709
Debt-free Net Working Capital (DFNWC)	11,874	14,665	9,838	5,506	2,159	6,194	-1,152	-2,783	-2,879	-1,727	-1,153
Net Working Capital (NWC)	-144	3,012	-3,716	-4,917	-7,538	-4,989	-10,041	-11,428	-13,108	-8,918	-10,666
Net Nonoperating Expense (NNE)	1,171	-523	-4,826	27	-380	-106	302	-150	-176	-172	226
Net Nonoperating Obligations (NNO)	11,366	12,408	16,455	19,436	19,805	18,539	21,700	24,279	26,361	22,979	24,950
Total Depreciation and Amortization (D&A)	3,134	3,078	2,820	2,834	2,824	3,013	2,735	2,807	2,714	2,896	2,847
Debt-free, Cash-free Net Working Capital to Revenue	0.38%	2.02%	-8.15%	-9.49%	-12.01%	-14.08%	-15.03%	-12.47%	-13.57%	-13.34%	-12.71%
Debt-free Net Working Capital to Revenue	16.78%	22.46%	15.12%	8.24%	3.19%	8.73%	-1.51%	-3.47%	-3.51%	-2.06%	-1.37%
Net Working Capital to Revenue	-0.20%	4.61%	-5.71%	-7.36%	-11.14%	-7.03%	-13.19%	-14.25%	-15.98%	-10.61%	-12.65%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.50	$3.80	$5.80	$0.00	$1.45	$5.13	$5.69	$6.00	$6.07	$6.18	$6.67
Adjusted Weighted Average Basic Shares Outstanding	2.71B	2.67B	2.55B	0.00	2.50B	4.97B	4.85B	4.78B	4.71B	2.35B	2.34B
Adjusted Diluted Earnings per Share	$2.44	$3.69	$5.59	$0.00	$1.43	$4.96	$5.50	$5.81	$5.90	$6.02	$6.51
Adjusted Weighted Average Diluted Shares Outstanding	2.71B	2.67B	2.55B	0.00	2.50B	4.97B	4.85B	4.78B	4.71B	2.35B	2.34B
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	2.71B	2.67B	2.55B	0.00	2.50B	4.97B	4.85B	4.78B	4.71B	2.35B	2.34B
Normalized Net Operating Profit after Tax (NOPAT)	8,315	10,081	10,585	9,888	9,039	12,997	14,654	14,643	14,562	15,872	16,291
Normalized NOPAT Margin	11.75%	15.44%	16.27%	14.80%	13.35%	18.32%	19.25%	18.26%	17.76%	18.89%	19.33%
Pre Tax Income Margin	15.56%	20.47%	20.38%	19.94%	8.97%	22.32%	23.14%	22.44%	22.38%	22.32%	23.93%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	18.35	23.78	29.14	26.85	12.49	34.72	36.00	41.87	24.87	20.77	22.72
NOPAT to Interest Expense	13.28	17.41	22.76	19.54	7.04	27.95	29.19	33.36	19.26	16.00	17.96
EBIT Less CapEx to Interest Expense	19.57	18.80	23.09	20.03	6.69	28.17	30.53	34.94	20.88	17.55	18.68
NOPAT Less CapEx to Interest Expense	14.50	12.43	16.71	12.73	1.24	21.41	23.72	26.42	15.27	12.78	13.92
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	102.00%	70.12%	46.95%	74.13%	189.06%	59.44%	57.57%	59.28%	61.06%	62.19%	61.45%
Augmented Payout Ratio	166.45%	107.88%	80.72%	145.16%	315.20%	115.96%	134.28%	126.90%	110.95%	95.62%	101.91%

This table displays calculated financial ratios and metrics derived from Procter & Gamble's official financial filings.

Metric	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	9/30/2023	12/31/2023	3/31/2024	6/30/2024	9/30/2024	12/31/2024	3/31/2025	6/30/2025	9/30/2025	12/31/2025	3/31/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	2,328,598,978.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	2,328,598,978.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	1.69
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	6.11%	3.22%	0.63%	-0.10%	-0.61%	2.06%	-2.07%	1.74%	2.99%	1.49%	7.38%
EBITDA Growth	14.98%	-4.68%	6.11%	-6.28%	-9.54%	25.14%	0.48%	12.79%	15.31%	-5.14%	8.06%
EBIT Growth	16.17%	-6.68%	6.62%	-8.56%	-11.12%	29.39%	1.02%	16.19%	16.80%	-7.36%	7.24%
NOPAT Growth	15.61%	-12.10%	8.23%	-5.36%	-0.68%	32.84%	1.03%	10.66%	3.16%	-6.30%	-2.32%
Net Income Growth	14.96%	-11.77%	10.43%	-7.31%	-12.49%	33.38%	0.32%	15.33%	19.91%	-7.04%	4.17%
EPS Growth	16.56%	-11.95%	10.95%	-7.30%	-12.02%	34.29%	1.32%	16.54%	21.12%	-5.32%	5.84%
Operating Cash Flow Growth	20.49%	42.70%	5.82%	7.73%	-12.28%	-5.39%	-9.37%	-13.36%	25.71%	3.05%	9.18%
Free Cash Flow Firm Growth	-46.91%	824.26%	2,026.29%	192.14%	153.21%	115.61%	-37.36%	-106.67%	-2.77%	-68.34%	6.87%
Invested Capital Growth	5.00%	2.61%	1.44%	0.15%	2.67%	1.67%	2.76%	5.03%	2.88%	4.26%	2.43%
Revenue Q/Q Growth	6.41%	-1.97%	-5.81%	1.67%	5.87%	0.67%	-9.62%	5.63%	7.17%	-0.80%	-4.38%
EBITDA Q/Q Growth	30.38%	-19.24%	1.89%	-12.65%	25.84%	11.72%	-18.18%	-1.94%	28.64%	-8.09%	-6.80%
EBIT Q/Q Growth	35.39%	-21.85%	2.39%	-15.59%	31.60%	13.77%	-20.07%	-2.92%	32.30%	-9.76%	-7.47%
NOPAT Q/Q Growth	35.78%	-23.95%	6.60%	-14.03%	42.50%	1.72%	-18.93%	-5.83%	32.84%	-7.61%	-15.49%
Net Income Q/Q Growth	34.32%	-23.33%	8.25%	-16.85%	26.81%	16.85%	-18.59%	-4.40%	31.85%	-9.41%	-8.77%
EPS Q/Q Growth	33.58%	-23.50%	8.57%	-16.45%	26.77%	16.77%	-18.09%	-3.90%	31.76%	-8.72%	-8.43%
Operating Cash Flow Q/Q Growth	-8.18%	4.00%	-19.84%	40.75%	-25.23%	12.16%	-23.21%	34.55%	8.49%	-8.06%	-18.64%
Free Cash Flow Firm Q/Q Growth	-4.47%	55.10%	68.35%	17.12%	-17.20%	32.07%	-51.09%	-112.48%	1,306.55%	-56.99%	65.08%
Invested Capital Q/Q Growth	1.00%	0.66%	1.12%	-2.58%	3.53%	-0.31%	2.20%	-0.43%	1.41%	1.03%	0.40%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	51.99%	52.69%	51.20%	49.60%	52.06%	52.39%	50.98%	49.11%	51.37%	51.22%	49.51%
EBITDA Margin	30.18%	24.86%	26.90%	23.11%	27.47%	30.49%	27.60%	25.62%	30.76%	28.49%	27.77%
Operating Margin	26.37%	20.68%	22.08%	18.92%	26.67%	26.24%	23.05%	20.85%	26.16%	24.16%	21.55%
EBIT Margin	26.97%	21.50%	23.37%	19.40%	24.12%	27.26%	24.11%	22.16%	27.36%	24.88%	24.08%
Profit (Net Income) Margin	20.83%	16.29%	18.72%	15.31%	18.34%	21.29%	19.18%	17.36%	21.36%	19.50%	18.61%
Tax Burden Percent	78.52%	77.69%	82.34%	81.22%	77.57%	79.71%	81.38%	80.20%	79.23%	79.89%	79.19%
Interest Burden Percent	98.36%	97.53%	97.29%	97.16%	98.04%	97.99%	97.76%	97.67%	98.53%	98.10%	97.57%
Effective Tax Rate	21.48%	22.31%	17.68%	18.75%	22.41%	20.31%	18.62%	19.80%	20.77%	20.11%	20.83%
Return on Invested Capital (ROIC)	23.82%	18.29%	20.39%	17.58%	23.10%	23.43%	20.57%	18.69%	22.79%	21.23%	18.85%
ROIC Less NNEP Spread (ROIC-NNEP)	23.92%	18.47%	20.79%	17.53%	21.07%	23.76%	20.90%	19.25%	23.37%	21.41%	20.16%
Return on Net Nonoperating Assets (RNNOA)	13.58%	10.63%	11.76%	8.86%	10.55%	11.91%	10.20%	8.97%	10.79%	10.27%	9.35%
Return on Equity (ROE)	37.40%	28.93%	32.15%	26.44%	33.65%	35.34%	30.76%	27.67%	33.58%	31.51%	28.20%
Cash Return on Invested Capital (CROIC)	16.08%	17.37%	18.56%	19.99%	17.04%	19.49%	18.13%	16.71%	18.42%	16.64%	18.03%
Operating Return on Assets (OROA)	18.81%	15.14%	16.41%	13.41%	16.25%	18.90%	16.68%	15.09%	18.29%	16.98%	16.61%
Return on Assets (ROA)	14.53%	11.47%	13.15%	10.58%	12.36%	14.76%	13.27%	11.82%	14.28%	13.31%	12.84%
Return on Common Equity (ROCE)	36.50%	28.24%	31.42%	25.85%	32.90%	34.58%	30.13%	27.10%	32.90%	30.87%	27.66%
Return on Equity Simple (ROE_SIMPLE)	32.15%	30.63%	30.41%	0.00%	27.79%	30.43%	29.81%	0.00%	0.00%	0.00%	0.00%
Net Operating Profit after Tax (NOPAT)	4,529	3,444	3,671	3,156	4,498	4,575	3,709	3,493	4,640	4,287	3,623
NOPAT Margin	20.71%	16.06%	18.18%	15.37%	20.69%	20.91%	18.76%	16.72%	20.73%	19.30%	17.06%
Net Nonoperating Expense Percent (NNEP)	-0.10%	-0.18%	-0.41%	0.05%	2.04%	-0.33%	-0.33%	-0.56%	-0.58%	-0.17%	-1.32%
Return On Investment Capital (ROIC_SIMPLE)	-	4.17%	-	-	-	5.31%	4.28%	4.02%	5.18%	4.77%	3.95%
Cost of Revenue to Revenue	48.01%	47.31%	48.80%	50.40%	47.94%	47.61%	49.02%	50.89%	48.63%	48.78%	50.49%
SG&A Expenses to Revenue	25.62%	25.75%	29.12%	30.68%	25.39%	26.15%	27.93%	28.26%	25.21%	27.05%	27.95%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	25.62%	32.01%	29.12%	30.68%	25.39%	26.15%	27.93%	28.26%	25.21%	27.05%	27.95%
Earnings before Interest and Taxes (EBIT)	5,899	4,610	4,720	3,984	5,243	5,965	4,768	4,629	6,124	5,526	5,113
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	6,601	5,331	5,432	4,745	5,971	6,671	5,458	5,352	6,885	6,328	5,898
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	7.11	7.06	7.70	7.82	7.94	7.84	7.71	7.24	6.81	6.36	6.20
Price to Tangible Book Value (P/TBV)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Price to Revenue (P/Rev)	4.00	4.02	4.51	4.60	4.83	4.68	4.73	4.40	4.21	3.90	3.84
Price to Earnings (P/E)	21.88	22.82	25.08	26.00	28.31	25.51	25.63	23.23	21.32	20.21	20.05
Dividend Yield	2.62%	2.61%	2.33%	2.34%	2.26%	2.36%	2.38%	2.58%	2.70%	2.94%	2.95%
Earnings Yield	4.57%	4.38%	3.99%	3.85%	3.53%	3.92%	3.90%	4.31%	4.69%	4.95%	4.99%
Enterprise Value to Invested Capital (EV/IC)	4.86	4.87	5.37	5.59	5.65	5.54	5.46	5.14	4.89	4.54	4.52
Enterprise Value to Revenue (EV/Rev)	4.33	4.34	4.82	4.89	5.13	4.98	5.04	4.71	4.51	4.22	4.14
Enterprise Value to EBITDA (EV/EBITDA)	16.12	16.46	18.08	18.59	20.04	18.42	18.53	16.93	15.73	14.96	14.67
Enterprise Value to EBIT (EV/EBIT)	18.38	18.86	20.71	21.39	23.19	21.11	21.20	19.27	17.84	17.07	16.78
Enterprise Value to NOPAT (EV/NOPAT)	23.77	24.76	27.07	27.76	29.11	26.40	26.53	24.37	23.34	22.28	22.37
Enterprise Value to Operating Cash Flow (EV/OCF)	20.40	18.95	20.87	20.71	22.37	22.16	22.77	22.28	20.25	18.85	18.49
Enterprise Value to Free Cash Flow (EV/FCFF)	30.98	28.43	29.16	27.98	33.61	28.65	30.51	31.52	26.94	27.87	25.35
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.75	0.69	0.64	0.64	0.69	0.67	0.65	0.66	0.67	0.69	0.68
Long-Term Debt to Equity	0.50	0.47	0.48	0.50	0.49	0.49	0.46	0.48	0.45	0.48	0.44
Financial Leverage	0.57	0.58	0.57	0.51	0.50	0.50	0.49	0.47	0.46	0.48	0.46
Leverage Ratio	2.59	2.55	2.50	2.49	2.49	2.43	2.36	2.41	2.40	2.39	2.34
Compound Leverage Factor	2.54	2.49	2.43	2.42	2.44	2.38	2.31	2.35	2.37	2.34	2.29
Debt to Total Capital	42.77%	40.84%	38.85%	39.10%	40.95%	40.27%	39.38%	39.76%	40.16%	40.73%	40.35%
Short-Term Debt to Total Capital	14.08%	12.86%	9.39%	8.66%	11.79%	10.94%	11.41%	10.96%	13.00%	12.30%	14.36%
Long-Term Debt to Total Capital	28.69%	27.98%	29.46%	30.44%	29.16%	29.33%	27.98%	28.80%	27.17%	28.43%	25.99%
Preferred Equity to Total Capital	0.97%	0.98%	0.97%	0.96%	0.90%	0.91%	0.90%	0.90%	0.86%	0.85%	0.83%
Noncontrolling Interests to Total Capital	0.38%	0.36%	0.33%	0.33%	0.34%	0.32%	0.31%	0.31%	0.31%	0.31%	0.25%
Common Equity to Total Capital	55.88%	57.82%	59.84%	59.61%	57.82%	58.49%	59.40%	59.03%	58.66%	58.11%	58.57%
Debt to EBITDA	1.60	1.52	1.43	1.47	1.68	1.52	1.49	1.47	1.48	1.53	1.51
Net Debt to EBITDA	1.17	1.17	1.12	1.04	1.12	1.07	1.10	1.06	1.02	1.07	1.01
Long-Term Debt to EBITDA	1.08	1.04	1.08	1.14	1.20	1.11	1.06	1.07	1.00	1.06	0.98
Debt to NOPAT	2.36	2.29	2.13	2.19	2.45	2.18	2.14	2.12	2.19	2.27	2.31
Net Debt to NOPAT	1.72	1.76	1.68	1.55	1.62	1.54	1.57	1.53	1.51	1.60	1.54
Long-Term Debt to NOPAT	1.59	1.57	1.62	1.71	1.74	1.59	1.52	1.53	1.48	1.59	1.49
Altman Z-Score	4.78	4.92	5.46	5.36	5.37	5.55	5.57	5.20	5.07	4.89	4.90
Noncontrolling Interest Sharing Ratio	2.41%	2.36%	2.28%	2.23%	2.22%	2.16%	2.07%	2.06%	2.03%	2.01%	1.90%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	0.67	0.64	0.69	0.73	0.75	0.76	0.71	0.70	0.71	0.72	0.73
Quick Ratio	0.17	0.18	0.40	0.46	0.51	0.49	0.45	0.44	0.46	0.47	0.49
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	996	1,544	2,599	3,044	2,521	3,329	1,628	-203	2,451	1,054	1,740
Operating Cash Flow to CapEx	531.89%	628.08%	561.54%	1,119.46%	453.80%	522.75%	440.02%	523.09%	453.69%	428.99%	757.49%
Free Cash Flow to Firm to Interest Expense	4.42	6.23	11.16	13.90	10.59	13.87	7.50	-0.96	12.44	4.79	7.80
Operating Cash Flow to Interest Expense	21.80	20.56	17.55	26.27	18.08	20.10	17.07	23.51	27.45	22.60	18.14
Operating Cash Flow Less CapEx to Interest Expense	17.70	17.29	14.42	23.93	14.09	16.26	13.19	19.02	21.40	17.33	15.74
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.70	0.70	0.70	0.69	0.67	0.69	0.69	0.68	0.67	0.68	0.69
Accounts Receivable Turnover	13.95	13.87	14.50	14.50	13.39	13.42	13.69	13.70	13.27	13.63	13.92
Inventory Turnover	5.77	5.67	5.65	5.80	5.66	5.79	5.65	5.65	5.50	5.67	5.65
Fixed Asset Turnover	3.94	3.88	3.86	3.81	3.80	3.82	3.75	3.66	3.64	3.66	3.67
Accounts Payable Turnover	2.90	2.94	2.99	2.73	2.74	2.86	2.90	2.69	2.69	2.83	2.92
Days Sales Outstanding (DSO)	26.16	26.31	25.17	25.17	27.25	27.19	26.67	26.64	27.51	26.78	26.22
Days Inventory Outstanding (DIO)	63.28	64.36	64.64	62.95	64.48	63.02	64.63	64.58	66.35	64.40	64.63
Days Payable Outstanding (DPO)	125.98	124.35	121.99	133.86	133.33	127.75	125.90	135.62	135.72	128.77	125.17
Cash Conversion Cycle (CCC)	-36.54	-33.67	-32.18	-45.75	-41.60	-37.54	-34.60	-44.41	-41.86	-37.58	-34.32
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	74,160	74,653	75,488	73,538	76,137	75,899	77,569	77,234	78,326	79,132	79,452
Invested Capital Turnover	1.15	1.14	1.12	1.14	1.12	1.12	1.10	1.12	1.10	1.10	1.10
Increase / (Decrease) in Invested Capital	3,533	1,900	1,072	112	1,977	1,246	2,081	3,696	2,189	3,233	1,883
Enterprise Value (EV)	360,665	363,917	405,560	410,956	430,428	420,343	423,214	396,997	383,233	359,374	358,876
Market Capitalization	333,385	336,992	379,330	386,908	405,340	394,823	397,135	370,996	357,407	332,517	333,171
Book Value per Share	$19.89	$20.25	$20.93	$20.97	$21.69	$21.39	$21.96	$21.85	$22.41	$22.37	$23.13
Tangible Book Value per Share	($7.21)	($6.57)	($5.74)	($5.45)	($5.09)	($4.82)	($4.61)	($5.26)	($4.68)	($4.76)	($3.93)
Total Capital	83,894	82,541	82,315	83,019	88,294	86,130	86,686	86,792	89,497	89,956	91,757
Total Debt	35,880	33,712	31,982	32,460	36,153	34,687	34,141	34,508	35,946	36,639	37,026
Total Long-Term Debt	24,069	23,096	24,253	25,269	25,744	25,263	24,252	24,995	24,315	25,577	23,852
Net Debt	26,147	25,822	25,154	22,978	23,997	24,457	25,025	24,952	24,775	25,814	24,720
Capital Expenditures (CapEx)	922	812	728	514	948	923	842	953	1,192	1,159	534
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-10,140	-10,113	-8,981	-11,209	-10,718	-8,961	-9,040	-10,709	-10,417	-9,874	-9,380
Debt-free Net Working Capital (DFNWC)	-407	-2,223	-2,153	-1,727	1,438	1,269	76	-1,153	754	951	2,926
Net Working Capital (NWC)	-12,218	-12,839	-9,882	-8,918	-8,971	-8,155	-9,813	-10,666	-10,877	-10,111	-10,248
Net Nonoperating Expense (NNE)	-27	-49	-110	12	511	-84	-84	-133	-141	-44	-328
Net Nonoperating Obligations (NNO)	26,146	25,824	25,155	22,979	23,996	24,456	25,024	24,950	24,775	25,815	24,721
Total Depreciation and Amortization (D&A)	702	721	712	761	728	706	690	723	761	802	785
Debt-free, Cash-free Net Working Capital to Revenue	-12.18%	-12.05%	-10.68%	-13.34%	-12.77%	-10.62%	-10.77%	-12.71%	-12.27%	-11.58%	-10.82%
Debt-free Net Working Capital to Revenue	-0.49%	-2.65%	-2.56%	-2.06%	1.71%	1.50%	0.09%	-1.37%	0.89%	1.12%	3.37%
Net Working Capital to Revenue	-14.67%	-15.30%	-11.76%	-10.61%	-10.69%	-9.67%	-11.69%	-12.65%	-12.81%	-11.86%	-11.82%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.89	$1.44	$1.56	$1.29	$1.65	$1.94	$1.58	$1.50	$2.00	$1.82	$1.66
Adjusted Weighted Average Basic Shares Outstanding	2.36B	2.35B	2.36B	2.35B	2.36B	2.34B	2.34B	2.34B	2.34B	2.32B	2.33B
Adjusted Diluted Earnings per Share	$1.83	$1.40	$1.52	$1.27	$1.61	$1.88	$1.54	$1.48	$1.95	$1.78	$1.63
Adjusted Weighted Average Diluted Shares Outstanding	2.36B	2.35B	2.36B	2.35B	2.36B	2.34B	2.34B	2.34B	2.34B	2.32B	2.33B
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	2.36B	2.35B	2.36B	2.35B	2.36B	2.34B	2.34B	2.34B	2.34B	2.32B	2.33B
Normalized Net Operating Profit after Tax (NOPAT)	4,529	4,486	3,671	3,156	4,498	4,575	3,709	3,493	4,640	4,287	3,623
Normalized NOPAT Margin	20.71%	20.92%	18.18%	15.37%	20.69%	20.91%	18.76%	16.72%	20.73%	19.30%	17.06%
Pre Tax Income Margin	26.53%	20.97%	22.74%	18.85%	23.65%	26.71%	23.57%	21.64%	26.95%	24.41%	23.49%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	26.22	18.59	20.26	18.19	22.03	24.85	21.97	21.83	31.09	25.12	22.93
NOPAT to Interest Expense	20.13	13.89	15.76	14.41	18.90	19.06	17.09	16.48	23.55	19.49	16.25
EBIT Less CapEx to Interest Expense	22.12	15.31	17.13	15.84	18.05	21.01	18.09	17.34	25.04	19.85	20.53
NOPAT Less CapEx to Interest Expense	16.03	10.61	12.63	12.07	14.91	15.22	13.21	11.98	17.50	14.22	13.85
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	58.93%	61.16%	60.12%	62.19%	65.72%	61.78%	62.68%	61.45%	59.17%	60.97%	60.97%
Augmented Payout Ratio	90.58%	87.08%	83.05%	95.62%	103.52%	106.43%	109.63%	101.91%	93.64%	94.72%	90.05%

Financials Breakdown Chart

Key Financial Trends

Here are the key trends for Procter & Gamble (NYSE: PG) based on the last four years of quarterly cash flow, income statement, and balance sheet data provided. The bullets prioritize items that may positively impact the stock, followed by neutral points, then potential negatives.

Strong quarterly profitability: Net income attributable to common shareholders has generally been in the roughly $3.6B–$4.8B range per quarter in 2024–2026, with trailing EPS typically around $1.5–$2.0 (for example, Q1 2026 net income to common was about $4.76B with EPS near $2.00).
Solid operating cash flow: Net cash from operating activities has consistently run about $4.0B–$5.5B per quarter, including Q1 2026 at $5.41B and Q2 2026 at $4.97B, underscoring durable cash generation.
Gross margins hold near 50%: For example, Q2 2026 shows Total Gross Profit of $11.374B on Revenue of $22.208B, roughly a 51% gross margin, indicating pricing power and cost discipline.
Solid liquidity: Cash & equivalents typically range around $9–12B, providing a liquidity cushion to fund dividends, buybacks, and ongoing investments.
Capital returns to shareholders: Regular per-share dividends (approx. $0.90–$1.06 quarterly) and ongoing share repurchases (e.g., $1.26B in Q1 2026 and $2.28B in Q2 2026) reflect a shareholder-friendly capital allocation approach.
Modest near-term acquisitions: Acquisition outlays are typically modest (often only single-digit millions), suggesting no large one-off expansion driving results.
Debt issuance and repayments vary: Quarter-to-quarter debt activity shows both issuance and repayments, which is a normal financing cadence rather than a clear long-term trend.
Elevated leverage: Total liabilities around $73–75B vs. equity around $53B, implying a debt-to-equity level in the ~1.4x range and a higher leverage profile to manage.
Financing cash outflows are meaningful: Net cash from financing activities is often negative (examples include roughly -$2.2B to -$4.1B in several quarters), reflecting dividends, buybacks, and debt activity.
Quarterly earnings variability: Some quarters show softer earnings (e.g., Q3 2025 and Q4 2025 with net income to common around $3.6–$3.8B), signaling seasonality and cyclicality in the consumer staples business.

05/09/26 03:21 AM ETAI Generated. May Contain Errors.

Procter & Gamble Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Procter & Gamble's fiscal year ends in June. Their fiscal year 2025 ended on June 30, 2025.

Procter & Gamble's net income appears to be on an upward trend, with a most recent value of $16.07 billion in 2025, rising from $7.14 billion in 2015. The previous period was $14.97 billion in 2024. See Procter & Gamble's forecast for analyst expectations on what's next for the company.

Procter & Gamble's total operating income in 2025 was $20.45 billion, based on the following breakdown:

Total Gross Profit: $43.12 billion
Total Operating Expenses: $22.67 billion

Over the last 10 years, Procter & Gamble's total revenue changed from $70.75 billion in 2015 to $84.28 billion in 2025, a change of 19.1%.

Procter & Gamble's total liabilities were at $72.95 billion at the end of 2025, a 1.6% increase from 2024, and a 9.8% increase since 2015.

In the past 10 years, Procter & Gamble's cash and equivalents has ranged from $0.00 in 2020 to $10.29 billion in 2021, and is currently $9.56 billion as of their latest financial filing in 2025.

Over the last 10 years, Procter & Gamble's book value per share changed from 22.61 in 2015 to 21.85 in 2025, a change of -3.4%.

Related Companies

Financial statements for NYSE:PG last updated on 4/28/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Procter & Gamble (PG) Financials

Financials Breakdown Chart

Key Financial Trends

Procter & Gamble Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Procter & Gamble (PG) Financials

Annual Income Statements for Procter & Gamble

Quarterly Income Statements for Procter & Gamble

Annual Cash Flow Statements for Procter & Gamble

Quarterly Cash Flow Statements for Procter & Gamble

Annual Balance Sheets for Procter & Gamble

Quarterly Balance Sheets for Procter & Gamble

Annual Metrics And Ratios for Procter & Gamble

Quarterly Metrics And Ratios for Procter & Gamble

Financials Breakdown Chart

Key Financial Trends

Procter & Gamble Financials - Frequently Asked Questions

When does Procter & Gamble's financial year end?

How has Procter & Gamble's net income changed over the last 10 years?

What is Procter & Gamble's operating income?

How has Procter & Gamble's revenue changed over the last 10 years?

How much debt does Procter & Gamble have?

How much cash does Procter & Gamble have?

How has Procter & Gamble's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools